Author

Qixiang Xu

Observed names: Qi-Xiang Xu, Qi-xiang Xu

Institution: Wannan Medical College

Observed institutions: Wannan Medical College, Capital Medical University, Beijing Anzhen Hospital

OpenAlex ID: A5079687655

Astragalus polysaccharide alleviates alcoholic-induced hepatic fibrosis by inhibiting polymerase I and transcript release factor and the TLR4/JNK/NF-κB/MyD88 pathway

2023 · Xu Sun, Yongqiu Zheng, et al. · Journal of Ethnopharmacology · 75

Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats

2023 · Shengpeng Zhang, Peng Zhu, et al. · Frontiers in Pharmacology · 36

Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats

2021 · Hui-hui Zhou, Ye-ming Zhang, et al. · Frontiers in Pharmacology · 15

Triptolide Attenuates Vascular Calcification by Upregulating Expression of miRNA-204

2021 · Yu-qiang Pei, Yong-qiu Zheng, et al. · Frontiers in Pharmacology · 12

Paeoniflorin Ameliorates Colonic Fibrosis in Rats with Postinfectious Irritable Bowel Syndrome by Inhibiting the Leptin/LepRb Pathway

2022 · Ya-Qing Tian, Sheng-Peng Zhang, et al. · Evidence-based Complementary and Alternative Medicine · 11

Azithromycin induces liver injury in mice by targeting the AMPK/Nrf2 pathway

2024 · Qixiang Xu, Cuifeng Zhang, et al. · Immunopharmacology and Immunotoxicology · 5

Cycloastragenol reduces inflammation and apoptosis in acute lung injury by inhibiting the NF-κB p65 and Akt pathways

2025 · Huixian Cheng, Qixiang Xu, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology

Works count: 7

Citation count: 154

H-index: 5

I10-index: 5